Published in Respir Physiol Neurobiol on December 10, 2008
Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice. J Neurosci (2010) 1.52
Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir Physiol Neurobiol (2009) 1.46
BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses. Exp Brain Res (2009) 1.42
Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. J Neurosci (2009) 1.36
A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome. J Neurosci (2012) 1.21
Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met. Curr Opin Neurobiol (2011) 1.12
Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome. Neuropsychopharmacology (2011) 1.09
The disruption of central CO2 chemosensitivity in a mouse model of Rett syndrome. Am J Physiol Cell Physiol (2011) 1.05
Breathing challenges in Rett syndrome: lessons learned from humans and animal models. Respir Physiol Neurobiol (2013) 1.04
Differences in breathing patterning during wakefulness in patients with mixed apnea-dominant vs obstructive-dominant sleep apnea. Chest (2011) 0.89
Common mechanisms of compensatory respiratory plasticity in spinal neurological disorders. Respir Physiol Neurobiol (2013) 0.86
Dysregulation of locus coeruleus development in congenital central hypoventilation syndrome. Acta Neuropathol (2015) 0.83
Inflammatory lung disease in Rett syndrome. Mediators Inflamm (2014) 0.82
Habituation without NMDA Receptor-Dependent Desensitization of Hering-Breuer Apnea Reflex in a Mecp2 Mutant Mouse Model of Rett Syndrome. Front Integr Neurosci (2011) 0.81
Characterization of Rett Syndrome-like phenotypes in Mecp2-knockout rats. J Neurodev Disord (2016) 0.80
Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives. Curr Clin Pharmacol (2013) 0.80
MeCP2 deficiency results in robust Rett-like behavioural and motor deficits in male and female rats. Hum Mol Genet (2016) 0.78
Enhanced dense core granule function and adrenal hypersecretion in a mouse model of Rett syndrome. Eur J Neurosci (2009) 0.77
Overview: the neurochemistry of respiratory control. Respir Physiol Neurobiol (2008) 0.77
Defects in brainstem neurons associated with breathing and motor function in the Mecp2R168X/Y mouse model of Rett syndrome. Am J Physiol Cell Physiol (2016) 0.77
A protocol for evaluation of Rett Syndrome symptom improvement by metabolic modulators in Mecp2-mutant mice. Curr Protoc Mouse Biol (2013) 0.75
Pathogenesis of Lethal Aspiration Pneumonia in Mecp2-null Mouse Model for Rett Syndrome. Sci Rep (2017) 0.75
Embryonic hindbrain patterning genes delineate distinct cardio-respiratory and metabolic homeostatic populations in the adult. Sci Rep (2017) 0.75
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84
Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci (2006) 13.32
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet (2001) 9.82
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science (2003) 8.81
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet (2001) 8.64
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (2003) 8.48
The story of Rett syndrome: from clinic to neurobiology. Neuron (2007) 8.08
Reversal of neurological defects in a mouse model of Rett syndrome. Science (2007) 7.09
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol (1983) 6.80
Transcription factors bind thousands of active and inactive regions in the Drosophila blastoderm. PLoS Biol (2008) 6.30
Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron (2002) 5.71
Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci (1995) 5.10
The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron (2006) 4.74
Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A (2005) 4.52
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet (2004) 4.45
MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron (2007) 4.15
Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci U S A (2007) 4.00
Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci (2006) 3.69
MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci (2004) 3.48
Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S A (2002) 3.29
Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci U S A (2005) 2.90
BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nat Neurosci (2003) 2.79
MeCP2 dysfunction in Rett syndrome and related disorders. Curr Opin Genet Dev (2006) 2.71
Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis (2005) 2.44
Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J Neurosci (2002) 2.33
Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci U S A (2007) 2.27
MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr Biol (2006) 2.25
Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J (2003) 2.21
Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J Neurosci (2005) 2.20
A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum Mol Genet (2008) 2.13
Activity-dependent release of endogenous brain-derived neurotrophic factor from primary sensory neurons detected by ELISA in situ. J Neurosci (2000) 1.97
Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol (2007) 1.93
Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiol Dis (2007) 1.90
Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain (2006) 1.88
Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum Mol Genet (2005) 1.87
Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J Neurosci (2007) 1.85
Neuropathology of Rett syndrome. J Child Neurol (2005) 1.83
Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol Cell Biol (2006) 1.79
Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-/y knockout mice. J Physiol (2007) 1.73
Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. Curr Drug Targets (2007) 1.64
MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. J Biol Chem (2007) 1.60
Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr Res (2006) 1.59
Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis (2001) 1.59
Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. J Neurosci (2000) 1.58
The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus (2008) 1.53
Gene expression patterns vary in clonal cell cultures from Rett syndrome females with eight different MECP2 mutations. BMC Med Genet (2002) 1.53
Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol Cell Biol (2006) 1.52
Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med Genet (2007) 1.49
Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport (1994) 1.49
EEG and respiration in Rett syndrome. Acta Neurol Scand (1991) 1.48
Mice lacking brain-derived neurotrophic factor exhibit visceral sensory neuron losses distinct from mice lacking NT4 and display a severe developmental deficit in control of breathing. J Neurosci (1996) 1.46
Rett syndrome: analysis of deaths in the British survey. Eur Child Adolesc Psychiatry (1997) 1.43
Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J Neurosci (2006) 1.41
FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet (2007) 1.39
Towards a full life with Rett disorder. Pediatr Rehabil (2002) 1.39
Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet (2006) 1.37
Neurophysiology of Rett syndrome. J Child Neurol (2005) 1.36
Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates. PLoS Biol (2005) 1.36
Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Curr Opin Neurol (2001) 1.30
Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor. J Neurophysiol (2006) 1.29
Reduction of biogenic amine levels in the Rett syndrome. N Engl J Med (1985) 1.26
Enhancement by an ampakine of memory encoding in humans. Exp Neurol (1997) 1.24
Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Eur J Neurosci (2007) 1.23
Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice. Hum Mol Genet (2008) 1.19
Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome. Ann Neurol (2003) 1.19
Brain-derived neurotrophic factor acutely inhibits AMPA-mediated currents in developing sensory relay neurons. J Neurosci (2000) 1.15
Maturation of the mammalian respiratory system. Physiol Rev (1999) 1.14
Expression of functional tyrosine kinase B receptors by rhythmically active respiratory neurons in the pre-Bötzinger complex of neonatal mice. J Neurosci (2003) 1.14
Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse. Neurosci Lett (2005) 1.13
Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol (1999) 1.12
Chronic elevation of brain-derived neurotrophic factor by ampakines. J Pharmacol Exp Ther (2003) 1.12
Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model. Respir Physiol Neurobiol (2007) 1.11
Brain-derived neurotrophic factor is required for normal development of the central respiratory rhythm in mice. J Physiol (1998) 1.10
Neurobiology of Rett syndrome: a genetic disorder of synapse development. Brain Dev (2001) 1.09
Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients. BMC Med Genet (2006) 1.08
Disturbances in cardiorespiratory function during day and night in Rett syndrome. Pediatr Neurol (2007) 1.08
Determinants of inspiratory activity. Respir Physiol Neurobiol (2005) 1.07
Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice. Pediatr Res (2006) 1.07
Spontaneous central apneas occur in the C57BL/6J mouse strain. Respir Physiol Neurobiol (2007) 1.05
Polysomnographic characteristics of patients with Rett syndrome. J Pediatr (1994) 1.02
Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol (1999) 1.01
Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome. Ann Neurol (1989) 1.01
Skewed X chromosome inactivation failed to explain the normal phenotype of a carrier female with MECP2 mutation resulting in Rett syndrome. Clin Genet (2007) 1.01
Rett syndrome neuropathology review 2000. Brain Dev (2001) 1.00
Effect of inspired oxygen on periodic breathing in methy-CpG-binding protein 2 (Mecp2) deficient mice. J Appl Physiol (1985) (2007) 1.00
Functional evidence of brain stem immaturity in Rett syndrome. Eur Child Adolesc Psychiatry (1997) 0.97
X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype. J Child Neurol (2008) 0.97
Rett syndrome: 1H spectroscopic imaging at 4.1 Tesla. J Child Neurol (1999) 0.97
Regulation of respiratory neuron development by neurotrophic and transcriptional signaling mechanisms. Respir Physiol Neurobiol (2005) 0.96
8-OH-DPAT suppresses spontaneous central apneas in the C57BL/6J mouse strain. Respir Physiol Neurobiol (2007) 0.96
Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers. Neuropsychopharmacology (2006) 0.95
High levels of cerebrospinal fluid glutamate in Rett syndrome. Pediatr Neurol (1996) 0.92
Rett syndrome: biogenic amines and metabolites in postmortem brain. Pediatr Neurol (1990) 0.92
Developmental changes in the BDNF-induced modulation of inhibitory synaptic transmission in the Kölliker-Fuse nucleus of rat. Eur J Neurosci (2007) 0.92
Substance P immunoreactivity in Rett syndrome. Pediatr Neurol (2000) 0.92
Serotonin transporter abnormality in the dorsal motor nucleus of the vagus in Rett syndrome: potential implications for clinical autonomic dysfunction. J Neuropathol Exp Neurol (2005) 0.91
Elevated CSF glutamate in Rett syndrome. Neuropediatrics (1992) 0.91
Developmental changes in brain-derived neurotrophic factor-mediated modulations of synaptic activities in the pontine Kölliker-Fuse nucleus of the rat. J Physiol (2007) 0.91
Autonomic cardiovascular control in methyl-CpG-binding protein 2 (Mecp2) deficient mice. Auton Neurosci (2007) 0.90
Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms. Brain Dev (2005) 0.89
A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nat Genet (2013) 2.59
Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J Neurosci (2002) 2.33
Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J Neurosci (2007) 1.85
Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice. J Neurosci (2010) 1.52
Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J Neurosci (2006) 1.41
Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. J Neurosci (2009) 1.36
A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome. J Neurosci (2012) 1.21
Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment. J Neurosci (2012) 1.18
Mutant mice reveal the molecular and cellular basis for specific sensory connections to inner ear epithelia and primary nuclei of the brain. Hear Res (2005) 1.15
Expression of functional tyrosine kinase B receptors by rhythmically active respiratory neurons in the pre-Bötzinger complex of neonatal mice. J Neurosci (2003) 1.14
Synaptic microcircuit dysfunction in genetic models of neurodevelopmental disorders: focus on Mecp2 and Met. Curr Opin Neurobiol (2011) 1.12
Endogenous brain-derived neurotrophic factor in the nucleus tractus solitarius tonically regulates synaptic and autonomic function. J Neurosci (2011) 1.06
Cranial sensory neuron development in the absence of brain-derived neurotrophic factor in BDNF/Bax double null mice. Dev Biol (2004) 1.05
Secretion of brain-derived neurotrophic factor from brain microvascular endothelial cells. Eur J Neurosci (2006) 0.98
Secretion of brain-derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling. J Neurochem (2005) 0.98
Expression of Phox2 transcription factors and induction of the dopaminergic phenotype in primary sensory neurons. Mol Cell Neurosci (2002) 0.94
Brain-derived neurotrophic factor enhances fetal respiratory rhythm frequency in the mouse preBötzinger complex in vitro. Eur J Neurosci (2008) 0.93
Development of pontine noradrenergic A5 neurons requires brain-derived neurotrophic factor. Eur J Neurosci (2005) 0.88
Decreased Hering-Breuer input-output entrainment in a mouse model of Rett syndrome. Front Neural Circuits (2013) 0.88
Neurotrophic factors in development and regulation of respiratory control. Compr Physiol (2013) 0.80
Enhanced dense core granule function and adrenal hypersecretion in a mouse model of Rett syndrome. Eur J Neurosci (2009) 0.77